Sign Out
ZAFIBRAL is contra-indicated in patients with severe liver dysfunction or primary biliary cirrhosis, and in those with severe renal disorders (serum creatinine values above 6 mg/100 mL).
As bezafibrate is normally highly protein bound it should not be given to patients with the nephrotic syndrome.
ZAFIBRAL is contra-indicated in patients hypersensitive to bezafibrate.
